Chronic Lymphocytic Leukemia New Reference: MRD-Guided CLL Treatment Ulas D. Bayraktar, MD 2025-09-08
GastroEsophageal Cancer New Protocol: Perioperative Durvalumab with FLOT in Gastric Cancer Ulas D. Bayraktar, MD 2025-09-08
Non-Small Cell Lung Cancer New Reference: Neoadjuvant Nivolumab for NSCLC Ulas D. Bayraktar, MD 2025-09-08
Head and Neck Cancer New Indication: Periop Pembrolizumab for Head and Neck Cancer Ulas D. Bayraktar, MD 2025-09-08
Anal Cancer New Reference: Retifanlimab + Chemotherapy for Advanced Anal Cancer Ulas D. Bayraktar, MD 2025-09-08
Multiple Myeloma New Drug: Linvoseltamab for Relapsed/Refractory Myeloma Ulas D. Bayraktar, MD 2025-09-08
Non-Small Cell Lung Cancer New Reference: Adagrasib for kRAS Mutated NSCLC Ulas D. Bayraktar, MD 2025-09-08
GastroEsophageal Cancer New Reference: Nivolumab and Ipilimumab for Advanced Gastric Cancer Ulas D. Bayraktar, MD 2025-09-08
Chronic Lymphocytic Leukemia New Reference: Pirtobrutinib for BTKi Pretreated CLL Ulas D. Bayraktar, MD 2025-09-08
Acute myeloid leukemia New Protocol: Revumenib with Azacitidine and Venetoclax for KMT2-Rearranged / NPM1-Mutated Ulas D. Bayraktar, MD 2025-09-08
